Pharmaceuticals

Interventional Lung Solutions Market Forecast 2026–2035: How to Leverage Market Growth

February 16, 2026March 11, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the interventional lung solutions market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Interventional Lung Solutions Market between 2026 and 2030?

The interventional lung solutions market has experienced robust expansion over the past few years. Forecasts indicate its expansion from $2.47 billion in 2025 to $2.68 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. Historically, this growth was primarily driven by factors such as the increasing prevalence of copd and lung cancer, limitations of surgical lung interventions, advancements in bronchoscopy technology, growing hospital adoption of minimally invasive procedures, and rising healthcare expenditure.

The interventional lung solutions market size is projected to experience substantial expansion in the coming years. It is anticipated to reach $3.66 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This anticipated growth during the forecast period is attributable to several factors, including an increase in the aging population suffering from respiratory illnesses, the growing embrace of robotic-assisted interventions, the expansion of pulmonary procedures performed on an outpatient basis, an amplified emphasis on detecting lung cancer early, and innovations in navigation bronchoscopy technology. Key trends shaping the market over the forecast period encompass the increasing acceptance of minimally invasive pulmonary techniques, a surge in the deployment of robotic bronchoscopy systems, escalating demand for devices designed for lung volume reduction, the broadening scope of image-guided interventional lung therapies, and a growing inclination towards single-use bronchoscopes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24258&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Interventional Lung Solutions Market?

The interventional lung solutions market is anticipated to expand due to the growing occurrence of respiratory illnesses. These diseases encompass various medical conditions impacting the lungs and airways, leading to breathing difficulties and impaired normal respiratory function. The escalating prevalence of respiratory conditions stems from increasing air pollution, which causes prolonged exposure to detrimental airborne particles and irritants. Interventional lung solutions address respiratory diseases through minimally invasive procedures, thereby enhancing lung function and alleviating symptoms in individuals with chronic pulmonary ailments. As an illustration, a report from BioMed Central Ltd, a UK-based journal website, in May 2025 indicated that the worldwide prevalence of chronic obstructive pulmonary disease stands at an estimated 10.3%, with projections suggesting 600 million individuals will be affected by 2050. Furthermore, approximately 262 million people globally are currently impacted by asthma. Consequently, the rising incidence of respiratory diseases acts as a primary catalyst for the interventional lung solutions market.

What Segments Are Included Within The Interventional Lung Solutions Market?

The interventional lung solutions market covered in this report is segmented –

1) By Product Type: Bronchoscopes, Endobronchial Ultrasound Needles, Pleuroscopes, Airway Stents, Other Product Types

2) By Technology: Robotic Surgery, Laser Therapy, Electromagnetic Navigation Bronchoscopy

3) By Procedure: Bronchoscopy, Thoracoscopy, Pleuroscopy, Other Procedures

4) By Application: Lung Cancer Treatment, Chronic Obstructive Pulmonary Disease

5) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) BY Bronchoscopes: Flexible Bronchoscopes, Rigid Bronchoscopes, Disposable Bronchoscopes

2) By Endobronchial Ultrasound Needles: Transbronchial Aspiration Needles, Biopsy Needles

3) By Pleuroscopes: Flexible Pleuroscopes, Semi-Rigid Pleuroscopes

4) By Airway Stents: Metallic Stents, Silicone Stents, Hybrid Stents

5) By Other Product Types: Bronchial Thermoplasty Devices, Lung Volume Reduction Devices, Electromagnetic Navigation Systems, Cryotherapy And Ablation Devices

Which Market Trends Are Opening Growth Opportunities In The Interventional Lung Solutions Market?

Companies operating within the interventional lung solutions market are prioritizing the development of innovative technologies, such as the Ion Endoluminal System. Their focus is on enhancing the accuracy of lung cancer diagnostics, enabling minimally invasive procedures, and improving patient outcomes through advanced navigation and biopsy functions. The Ion Endoluminal System is a robotic-assisted platform specifically engineered for minimally invasive lung interventions, providing precise airway navigation to access small or hard-to-reach lung nodules. For instance, in April 2024, H. Lee Moffitt Cancer Center and Research Institute Foundation Inc., a US-based non-profit institution, launched a new Ion Robotic Bronchoscopy platform, which significantly advanced their interventional pulmonology program by incorporating sophisticated fiber-optic technology and a minimally invasive catheter system. This technology utilizes fiber optics and the smallest catheter available to reach all areas of the lung. This platform features an ultra-thin, highly maneuverable catheter with 180° articulation, alongside integrated real-time vision and shape-sensing technology, facilitating accurate navigation and biopsy of peripheral lung nodules that are challenging to access. This system offers unprecedented stability and precision for tissue sampling, allowing physicians to reach all 18 lung segments and ultimately improving the early detection of lung cancer.

Who Are The Prominent Global Companies Shaping The Interventional Lung Solutions Market Landscape?

Major companies operating in the interventional lung solutions market are Johnson and Johnson, Siemens AG, Medtronic plc, FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smiths Medical Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., Vapotherm Inc., Pulmonx Corporation, Broncus Medical Inc., Thirona B.V., Body Vision Medical Ltd., EndoMed Systems GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/interventional-lung-solutions-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Interventional Lung Solutions Market?

North America was the largest region in the interventional lung solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional lung solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Interventional Lung Solutions Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24258&type=smp

Browse Through More Reports Similar to the Global Interventional Lung Solutions Market 2026, By The Business Research Company

Artificial Lung Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Lower Respiratory Tract Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/lower-respiratory-tract-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795